Full Project List

Since our inception as an outcome committee in 2015, we have consistently and considerably expanded our ability to produce rigorous outcomes research. In 2018, we established a more formal program and leadership, including full time outcomes research staff. The result of these allocated resources has been a productive output across multiple specialty disease states. Below are highlighted outcomes from studies completed in recent years.

Sponsored Projects:

Zuckerman A, Peter M, Cooper K, Jones A, Choi L, DeClercq J, Tanner SB, James C, Choi J. Impact of pharmacist collaborative practice in rheumatoid arthritis. Source: Sanofi Inc. December, 2018.

Horst S, Shah N, Wolever R, Schwartz D, Beaulieu D, Dalal R, Zuckerman A. Health coaching to improve medication in IBD. Source: AbbVie Inc. December, 2018.

Koren D, Martin M, Zuckerman A, Teply R, Nabulsi N, Lee T. Expanding hepatitis c virus care and cure: national experience using a clinical pharmacist-driven model. Source: Gilead Science, Inc. December, 2017.

Peer-Reviewed Manuscript Publications:


Forthcoming

Livezey S, Shah NB, McCormick R, Choi L, DeClercq J, Zuckerman A. Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access. MHC, Forthcoming.

Published Manuscripts

Zuckerman AD, Shah NB, Peter ME, Jolly JA, Kelley TN. Development, implementation and evaluation of a health outcomes and research program at an integrated health-system specialty pharmacy. Am J Health Syst Pharm. 2021 Mar 9:zxab082. doi: 10.1093/ajhp/zxab082.

Anguiano RH, Zuckerman AD, Hall E, Diamantides E, Kumor L, Duckworth DL, Peter M, Sorgen PJ, Nathanson A, Kandah HM, Dura J, Campbell U. Provider satisfaction with specialty pharmacy services comparing the integrated health-system to external practice models: A multi-site survey. Am J Health Syst Pharm. 2021 Mar 2:zxab079. doi: 10.1093/ajhp/zxab079.

Goettel A, DeClercq J, Choi L, Graham TB, Mitchell A. Efficacy and safety of abatacept, adalimumab, and etanercept in pediatric patients with juvenile idiopathic arthritis. JPPT, 2021; 26(2): 157–162.

Peter ME, Markley B, DeClercq J, Choi L, Givens G, Zuckerman AD, Banks A. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health system specialty pharmacy. J Manag Care Spec Pharm, 2021 Feb;27(2):256-262. doi: 10.18553/jmcp.2021.27.2.256.

Berger N, Peter M, DeClercq J, Choi L, Zuckerman AD. Rheumatoid arthritis medication adherence in a health-system specialty pharmacy. Am J Manag Care, 2020 Dec 1;26(12):e380-e387. doi: 10.37765/ajmc.2020.88544.

Carver AB, Zuckerman A, DeClercq J, Choi L, Chastain CA. Incidence and impact of persistent viremia on SVR rates in patients receiving direct acting antiviral therapy. OFID, ofaa569, https://doi.org/10.1093/ofid/ofaa569.

Kibbons AM, Peter M, DeClercq, Choi L, Bell J, Jolly J, Cherry E, Alhashemi B, Shah NB, Zuckerman AD. Pharmacist Interventions to Improve Specialty Medication Adherence: Study Protocol for a Randomized Controlled Trial. Drugs - Real World Outcomes (2020). https://doi.org/10.1007/s40801-020-00213-8.

Nabulsi NA, Martin MT, Sharp LK, Koren DE, Teply R, Zuckerman A, Lee TA. Predicting treatment failure for initiators of hepatitis C virus treatment in the era of direct-acting antiviral therapy. Front. Pharmacol, 2020 Nov 13; 11 (1732). doi: 10.3389/fphar.2020.551500.

Wyatt H, Peter M, Zuckerman A, Starks S, Maulis M, Declercq J, Choi L, Jagasia M. Assessing the impact of limited distribution drug networks on time to access oral oncolytic agents at an integrated specialty pharmacy. JHOP, Aug2020, 10 (4), 198-205.

Crothers G, Shah NB, Kim M, Zuckerman AD. Development of a quality measures tool for the utilization of tyrosine kinase inhibitors in non-small cell lung cancer: An integrated specialty pharmacy initiative. J Oncol Pharm Pract, DOI: 10.1177/1078155220937754

Zuckerman AD, Patel PC, Sullivan M, Potts A, Knostman M, Humphreys E, O’Neal M, Bryant A, Torr D, Lobo B, Peek G, Kelley T, Manfred J, Tomichek J, Crothers G, Catlin R, Brumagin HE, Hughes L, Hayman J. From natural disaster to pandemic: A health-system pharmacy rises to the challenge. AJHP, zxaa180, https://doi.org/10.1093/ajhp/zxaa180

Rathbun RC, Durham SH, Farmer KC, Zuckerman AD, Badowski M. Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States. Curr Pharm Teach Learn, 2020 Aug; 12(8): 910-917. Available online 16 April 2020. DOI: 10.1016/j.cptl.2020.04.007

Rotolo SM, Duehlmeyer S, Slack SM, Jacobs HR, Heckman B. Testicular pain following initiation of elexacaftor / tezacaftor / ivacaftor in males with cystic fibrosis. J Cyst Fibros. Forthcoming

Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Harrell S, Rubinstein SM, Hall R, Wyatt H, Piazza G. Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents. Br J Haematol, 2020 Apr; doi: 10.1111/bjh.16653

Schlendorf KH, Zalawadiya S, Shah AS, et al. Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C. JAMA Cardiol. Published online December 18, 2019. doi: https://doi.org/10.1001/jamacardio.2019.4748

Zuckerman AD, Douglas A, Whelchel K, Choi L, DeClercq J, Chastain CA. Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter? PLoS ONE, 2019 Nov; 14(11): e0225434 doi: 10.1371/journal.pone.0225434

Zuckerman A, Carver A, Cooper K, Markley B, Mitchell A, Reynolds VW, Saknini M, Wyatt H, Kelley T. Transitions of care: a focus on specialty medication challenges and specialty pharmacist opportunities. Pharmacy, 2019 Dec; 7, 163. doi:10.3390/pharmacy7040163

Paolella D, Cherry E, Jolly J, DeClercq J, Choi L, Zuckerman A. Closing the gap: identifying rates and reasons for nonadherence in a specialty population. J Manag Care Spec Pharm, 2019 Nov; 25(11): 1282-1288. doi: 10.18553/jmcp.2019.25.11.1282

Shah NB, Haydek J, Slaughter J, Ashton JR, Zuckerman AD, Wong R, Raffa F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu D, Schwartz D, Horst SN. Risk factors for medication nonadherence to self-injectable biologic therapy in adult patients with inflammatory bowel disease. Inflamm Bowel Dis, 2019 Oct; pii: izz253. doi: 10.1093/ibd/izz253.

Canfield SL , Zuckerman A, Anguiano RH, Jolly JA, DeClercq J, Wascher M, Choi L, Knox S, Mitchell DF. Navigating the wild west of medication adherence reporting in specialty pharmacy. J Manag Care Spec Pharm, 2019 Oct; 25(10):1073-1077. https://doi.org/10.18553/jmcp.2019.25.10.1073

Shah NB, Jolly JA, Horst SN, Peter M, Limper H, Zuckerman AD. Development of a quality measures tool for the use of self-injectable biologic therapy in inflammatory bowel disease: an integrated specialty pharmacy initiative. Am J Health Syst Pharm, 2019 Sep; 76(17): 1296-1304

Merchant SL, Culos K, Wyatt H. Ivosidenib: idh1 inhibitor for the treatment of acute myeloid leukemia. J Adv Pract Oncol, 2019 Jul; 10(5):494-500.

Koren D, Zuckerman A, Teply R, Nabulsi N, Lee T, Martin M. Expanding hepatitis c virus care and cure: national experience using a clinical pharmacist-driven model. Open Forum Infect Dis, 2019 Jul; 6(17):ofz316. doi:10.1093/ofid/ofz316.

Shah NB, Mitchell RE, Proctor ST, Choi L, DeClercq J, Jolly JA, Hemnes AR, Zuckerman AD. High rates of medication adherence in patients with pulmonary arterial hypertension: an integrated specialty pharmacy approach. PloS One, 2019 Jun; 14(6):e0217798. doi: 10.1371/journal.pone.0217798.

Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Patton D, Harrell S, Hall R, Wyatt H. Apixaban for primary prevention of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory therapy. Front Oncol, 2019 Feb; 9(45). doi: 10.3389/fonc.2019.00045.

Banks AM, Peter ME, Holder GM, Jolly JA, Markley BM, Zuckerman SL, Choi L, Nwosu S, Zuckerman AD. Adherence to disease-modifying therapies at a multiple sclerosis clinic: the role of the specialty pharmacist. J Pharm Pract, 2019 Jan; :897190018824821. doi: 10.1177/0897190018824821.

Reynolds VW, Chinn ME, Jolly JA, Kelley TN, Peter ME, Choi L, Nwosu S, Leon BC, Zuckerman AD. Integrated specialty pharmacy yields high pcsk9 inhibitor access and initiation rates. J Clin Lipidol, 2019 Jan; 13(2):254-264. doi: 10.1016/j.jacl.2019.01.003. Epub 2019 Jan 14.

Zuckerman A, Carver A, Chastain CA. Building a hepatitis c clinical program: strategies to optimize outcomes. Curr Treat Options Infect Dis, 2018 Oct; 10(4):431-446. doi: 10.1007/s40506-018-0177-5. Epub 2018 Oct 18.

Zuckerman A, Douglas A, Nwosu S, Choi L, Chastain C. Increasing success and evolving barriers in the hepatitis c cascade of care during the direct acting antiviral era. PloS One, 2018 Jun; 13(6):e0199174. doi: 10.1371/journal.pone.0199174.

Schlendorf KH, Zalawadiya S, Shah AS, Wigger M, Chung CY, Smith S, Sacks SB. Early outcomes using hepatitis c–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. J Heart Lung Transplant, 2018 Jun; 37(6):763-769. doi: 10.1016/j.healun.2018.01.1293. Epub 2018 Jan 31

Zuckerman A, Chastain CA, Naggie S. Retreatment options following HCV direct-acting antiviral failure. Curr Treat Options Infect Dis, 2017 Dec; 9(4):389-402. doi: 10.1007/s40506-017-0136-6. Epub 2017 Nov 4

Bagwell A, Kelley T, Carver A, Lee JB, Newman B. Advancing patient care through specialty pharmacy services in an academic health system. J Manag Care Spec Pharm, 2017 Aug; 23(8):815-820. doi: 10.18553/jmcp.2017.23.8.815.

Bagwell A, Chastain CA. Hepatitis c treatment in HIV coinfection: approaches, challenges, and future opportunities. Curr Treat Options Infect Dis, 2016 Oct; 8(4):379-399. doi: 10.1007/s40506-016-0097-1.

Conference Podium presentations:

Chelewski R, Johnson K, Zuckerman A, Peter M, Langone A. Assessing interventions to improve patient care conducted by pharmacists at an outpatient renal transplant clinic within a collaborative pharmacy practice agreement. Podium presentation presented to the American Transplant Congress Annual Meeting, Virtual Meeting. June, 2020

Chelewski R, Johnson K, Zuckerman A, DeClercq J, Choi L, Peter M, Langone A. Development of a pharmacy collaborative practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Podium presentation presented to the American Transplant Congress Annual Meeting, Boston, MA. June, 2019.

Boyle K, Edmonds C, Schlendorf K, Gray J, Lindenfeld J, Pollack A, Fowler R. Appropriate management of drug interactions results in safe use of hepatitis c therapies in heart transplant recipients. Podium presentation presented to The International Society for Heart & Lung Transplantation Annual Meeting, Orlando, FL. April, 2019.

Goettel A. Efficacy and safety of abatacept, adalimumab, and etanercept in pediatric patients with juvenile idiopathic arthritis. Podium presentation presented to the Pediatric Pharmacy Advocacy Group Annual Meeting, Oklahoma City, OK. April, 2019.

O’Dell HW, Darragh CR, Smith SS, Schlendorf K, Perri RE, Awad J, Shah AS, Edmonds C, Carver A, Chung CY. Multispecialty collaboration benefits efforts at expanding donor pools: transplanting HCV positive grafts into HCV negative heart transplant recipients. Podium presentation presented to the American Association of the Study of Liver Diseases (AASLD) The Liver Meeting, San Francisco, CA. November, 2018.

Haydek J, Shah N, Slaughter JC, Ashton J, Zuckerman A, Wong R, Raffa F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu D, Schwartz D, Horst S. Risk factors for non-adherence to biologic therapy in adult patients with inflammatory bowel disease (IBD): a retrospective analysis. Podium presentation presented to the American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA. October, 2018.

Chastain C, Johnson J, Miller K, Moore K, Lako A, Zuckerman A, Han J, Self W. Universal hepatitis c screening in a Tennessee tertiary care emergency department. Podium presentation presented to ID Week, San Francisco, CA. October, 2018.

Conference Poster presentations:

Cherry L, Vimathalas P, Shah NB, DeClercq J, Zuckerman A, Choi L, Horst S. Persistence, discontinuation and specialty pharmacist interventions in patients receiving droxidopa for the management of orthostatic hypotension. Poster presented at: American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition; December, 2020; Virtual Meeting.

Daniell J, Shah NB, DeClercq J, Choi L, Zuckerman A, Livezey S. Clinical characteristics and three-month outcomes of patients prescribed alternate-dose self-injectable biologic therapy for the management of inflammatory bowel disease. Poster presented at: American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition; December, 2020; Virtual Meeting.

Hall N, Rizvi F, DeClercq J, Choi L, Donald D, Reynolds V. Exploring rates of PCSK9 inhibitor persistence and reasons for treatment non-persistence in an integrated specialty pharmacy model. Poster presented at: American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition; December, 2020; Virtual Meeting.

Rizvi F, Hall N, DeClercq J, Choi L, Donald D, Reynolds V. Real-world use of PCSK9 inhibitors and adherence to guideline-directed therapy in an integrated specialty pharmacy. Poster presented at: American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition; December, 2020; Virtual Meeting.

Morton S, Reynolds V, Wyatt K, DeClercq J, Choi L, Peter M. Rates and reasons for medication switching and cycling in patients with rheumatoid arthritis at an integrated health system specialty pharmacy. Poster presented at: American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition; December, 2020; Virtual Meeting.

Truong V, Looney B, Moore R, Zuckerman A, Shah NB. PARP Inhibitor Therapy Initiation: Patient Characteristics and Treatment Access Considerations. Poster presented at: American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition; December, 2020; Virtual Meeting.

Alhashemi B, Kibbons AM, Peter M, Zuckerman AD. Identifying misidentified nonadherence to specialty medications: comparing rates and reasons behind nonadherence. Poster presented at: American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition; December, 2020; Virtual Meeting.

Whelchel K, Zuckerman AD, Koren D, Derrick C, Bouchard J, Chastain C. Crushing and splitting DAAs for HCV treatment: a case series. Poster presented at: The Liver Meeting; November, 2020; Virtual Meeting.

Reynolds VW, Moulton D, Yarwais M, Hawkins S, Mitchell A, DeClercq J, Choi L. Evaluation of response to adalimumab dose intensification in pediatric patients with inflammatory bowel disease. Poster presented at: North American Society for Pediatric Gastroenterology, Hepatology & Nutrition; November, 2020; Virtual Meeting.

Wiles CA, Shah NB, Bell J, Pabla BS, Scoville E, Dalal R, Beaulieu D, Schwartz D, Horst SN. Tofacitinib adherence and outcomes in patients with refractory ulcerative colitis. Poster presented to American College of Gastroenterology Annual Meeting, Virtual Meeting. October, 2020

Coe C, Cherry L, Shah NB, Zuckerman A, DeClercq J, Choi L, Pabla B, Scoville E, Dalal R, Beaulieu B, Schwartz D, Horst S. Alternative subcutaneous biologic dosing in inflammatory bowel disease is delayed depending on insurance approval requirements. Poster presented to American College of Gastroenterology Annual Meeting, Virtual Meeting. October, 2020. Awarded ACG Outstanding poster presenter" award

Whelchel K, Zuckerman AD, DeClercq J, Choi L, Rashid S, Kelly S. Overcoming prescriber concerns through successful access and affordability of PrEP. Poster presented to ID Week, Virtual Meeting. October, 2020

Whelchel K, Zuckerman AD, DeClercq J, Choi L, Rashid S, Kelly S. Extended adherence and persistence to HIV PrEP in a multidisciplinary PrEP clinic. Poster presented to ID Week, Virtual Meeting. October, 2020

Kibbons AM, Peter M, Bell J, Jolly J, Zuckerman AD. Identifying nonadherence to specialty medications: comparing pharmacy claims data and individual reasons for nonadherence. Poster presented to AMCP Nexus Annual Conference, Virtual Meeting. October, 2020

Chelewski RJ, Johnson KE, Zuckerman AD, Peter M, Langone A. Assessing interventions to improve patient care conducted by pharmacists at an outpatient renal transplant clinic within a collaborative pharmacy practice agreement. Encore poster presented to the AMCP Nexus Annual Conference, Virtual Meeting. October, 2020

Zuckerman AD, DeClercq, J, Cowgill N, McCarthy K, Lounsbery B, Shah R, Kehasse A, Thomas K, Sokos L, Stutsky M, Young J, Carter J, Lach M, Wise K, Thomas TT, Ortega M, Jinkyu Lee, Lewis K, Dura J, Gazda N, Gerzenshtein L, Canfield S. Health-Systems Specialty Pharmacy Outcomes Research Consortium. Specialty Medication Adherence Rates in Patients with Rheumatoid Arthritis Across Health-System Specialty Pharmacies. Poster presented to AMCP, October 2020.

Edmonds C, Carver A, DeClercq J, Choi L, Peter M, Forbes R, Concepcion B, Schlendorf K, Perri R. Access to direct acting antiviral therapy for recipients of solid organs from hepatitis-c-viremic donors. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020. *Awarded Top Poster for “Specialty Pharmacy Services” category

Chelewski R, Johnson K, Zuckerman A, Peter M, Langone A. Assessing interventions to improve patient care conducted by pharmacists at an outpatient renal transplant clinic within a collaborative pharmacy practice agreement. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020.

Gipson HM, Gregory WT, Chakrabarti A, DeClercq J, Choi L, Peter M. Assessing rates and reasons for treatment lapses in patients treated with denosumab. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020.

Givens G, Banks A, DeClercq J, Choi L, Zuckerman A, Peter M. Impact of an integrated specialty pharmacy model on patient access to dalfampridine. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020.

Gregory WT, Gipson HM, Chakrabarti A, Peter M. Rates, reasons, and timing for treatment discontinuation in patients prescribed denosumab. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020.

Mitchell E, McDonald A, Reynolds V, Shah N, Peter M, DeClercq J, Choi L, Zuckerman A. Modeling rates of primary medication nonadherence with specialty oncolytic agents. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020. *Awarded Top Poster for “Adherence” category

McDonald A, Mitchell E, Reynolds V, Shah N, Peter M, DeClercq J, Choi L, Zuckerman A. Assessing reasons for primary medication non-adherence in oncology specialty medications. Encore poster presented at: National Association of Specialty Pharmacy Annual Conference; September, 2020; Virtual Meeting.

Livezey S, Daniell J, DeClercq J, Choi L, Zuckerman A, Shah N. Persistence on droxidopa for the management of orthostatic hypotension at an integrated care center. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020.

Lanham HT, Bowles M, Schneider M, Shah N, DeClercq J, Zuckerman A. Evaluating prescription outcomes for specialty agents used to treat dermatologic conditions: a quality improvement initiative. Encore poster presented to National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020.

Edmonds C, Carver A, DeClercq J, Choi L, Peter M, Forbes R, Concepcion B, Schlendorf K, Perri R. Access to direct acting antiviral therapy for recipients of solid organs from hepatitis-c-viremic donors. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Chelewski R, Johnson K, Zuckerman A, Peter M, Langone A. Assessing interventions to improve patient care conducted by pharmacists at an outpatient renal transplant clinic within a collaborative pharmacy practice agreement. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Gipson HM, Gregory WT, Chakrabarti A, DeClercq J, Choi L, Peter M. Assessing rates and reasons for treatment lapses in patients treated with denosumab. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Givens G, Banks A, DeClercq J, Choi L, Zuckerman A, Peter M. Impact of an integrated specialty pharmacy model on patient access to dalfampridine. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Gregory WT, Gipson HM, Chakrabarti A, Peter M. Rates, reasons, and timing for treatment discontinuation in patients prescribed denosumab. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

McDonald A, Mitchell E, Reynolds V, Shah N, Peter M, DeClercq J, Choi L, Zuckerman A. Assessing reasons for primary medication non-adherence in oncology specialty medications. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Mitchell E, McDonald A, Reynolds V, Shah N, Peter M, DeClercq J, Choi L, Zuckerman A. Modeling rates of primary medication nonadherence with specialty oncolytic agents. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Livezey S, Daniell J, DeClercq J, Choi L, Zuckerman A, Shah N. Persistence on droxidopa for the management of orthostatic hypotension at an integrated care center. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Lanham HT, Bowles M, Schneider M, Shah N, DeClercq J, Zuckerman A. Evaluating prescription outcomes for specialty agents used to treat dermatologic conditions: a quality improvement initiative. Encore poster presented to the 2020 Vanderbilt Health Systems Specialty Pharmacy Outcomes Research Summit, Virtual Meeting. August 2020.

Edmonds C, Carver A, DeClercq J, Choi L, Peter M, Forbes R, Concepcion B, Schelendorf K, Perri R. Access to direct acting antiviral therapy for recipients of solid organs from hepatitis C viremic donors. Poster presented to American Transplant Congress, Virtual Meeting. June, 2020

Causey EE, George L, Rossmann L, Shah NB, Zuckerman A, Slaughter J, Duley C, Annis K, Wagnon J, Dalal R, Scoville E, Beaulieu DB, Schwartz D, Cross RK, Horst SN. Risk factors for non-adherence to self-injectable biologic therapy in inflammatory bowel disease: a validation cohort study. Presented to Digestive Disease Week, Virtual Meeting. May, 2020.

Chelewski R, Johnson K, Zuckerman A, Peter M, Langone A. Assessing interventions to improve patient care conducted by pharmacists at an outpatient renal transplant clinic within a collaborative pharmacy practice agreement. Poster presented to Academy of Managed Care and Specialty Pharmacy Annual Meeting, Virtual Meeting. April, 2020.

Livezey S, Daniell J, DeClercq J, Choi L, Zuckerman A, Shah N. Persistence on droxidopa for the management of orthostatic hypotension at an integrated care center. Poster presented to 23rd Annual Meeting of the College of Psychiatric and Neurologic Pharmacists, Virtual Meeting. April, 2020.

Givens G, Banks A, DeClercq J, Choi L, Zuckerman A, Peter M. Impact of an integrated specialty pharmacy model on patient access to dalfampridine. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Las Vegas, NV. December, 2019.

Gipson HM, Gregory WT, Chakrabarti A, DeClercq J, Choi L, Peter M. Assessing rates and reasons for treatment lapses in patients treated with denosumab. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Las Vegas, NV. December, 2019.

Gregory WT, Gipson HM, Chakrabarti A, Peter M. Rates, reasons, and timing for treatment discontinuation in patients prescribed denosumab. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Las Vegas, NV. December, 2019.

Lanham HT, Bowles M, Schneider M, Shah N, DeClercq J, Zuckerman A. Evaluating prescription outcomes for specialty agents used to treat dermatologic conditions: a quality improvement initiative. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Las Vegas, NV. December, 2019.

McDonald A, Mitchell E, Reynolds V, Shah N, Peter M, DeClercq J, Choi L, Zuckerman A. Assessing reasons for primary medication non-adherence in oncology specialty medications. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Las Vegas, NV. December, 2019.

Mitchell E, McDonald A, Reynolds V, Shah N, Peter M, DeClercq J, Choi L, Zuckerman A. Modeling rates of primary medication nonadherence with specialty oncolytic agents. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Las Vegas, NV. December, 2019.

Byrne MT, Danielson N, Rasche A, Hammers R, Culos KA, Gatwood KS, Wyatt H, Fogo K, Dholaria B, Engelhardt BG, Ferrell PB, Jagasia M, Kassim AA, Mohan SR, Savani BN, Strickland SA, Sengsayadeth SM. Venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse in acute myeloidleukemia. Poster presented to the American Society of Hematology, Orlando, FL. December, 2019.

Koren D, Zuckerman A, Teply R, Nabulsi N, Lee T, Martin M. Hepatitis C virus sustained virologic response rates in African Americans. Poster presented to the American Association of the Study of Liver Diseases (AASLD) The Liver Meeting, Boston, MA. November, 2019.

Zuckerman A, James C, Choi J, Peter M, Nadler MA, Nola KM, Jones A, Cooper K, DeClercq J, Choi L, Tanner SB. Switching and cycling among patients with rheumatoid arthritis at an integrated health system specialty pharmacy. Poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, National Harbor, MD. October, 2019.

Livezey S, McCormick R, Shah N, Choi L, DeClercq J, Zuckerman A. Impact of specialty pharmacist integration on time to medication access for pimavanserin. Encore poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, National Harbor, MD. October, 2019.

Tolle J, Slack S, Miller A, Eastman S, Hinton K, Jones S, Glenn S, Patel B. Implementing a medication reconciliation protocol for adult cystic fibrosis patients in an integrated outpatient clinic. Poster presented to the North American Cystic Fibrosis Conference, Nashville, TN. October, 2019.

Moore E, Kelly S, Alexander L, Luther P, Cooper R, Rebeiro P, Zuckerman A, Hargreaves M, Bourgi K, Schlundt D, Bonnet K, Pettit A. Healthcare provider attitudes and knowledge around pre-exposure prophylaxis (PrEP) for the prevention of HIV-infection in Tennessee. Poster presented at ID Week 2019. Washington, DC. October, 2019.

Livezey S, McCormick R, Shah N, Choi L, DeClercq J, Zuckerman A. Impact of specialty pharmacist integration on time to medication access for pimavanserin. Encore poster presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Nix R, Looney B, Lamb C, Peter M, Zuckerman A. A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regorafenib. Encore poster presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Chelewski R, Johnson K, Zuckerman A, DeClercq J, Choi L, Peter M, Langone A. Development of a collaborative pharmacy practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Encore poster presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Wyatt H, Zuckerman A, Peter M, Starks S, Maulis M, Declercq J, Choi L, Jagasia M. Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks. Encore poster presented to the National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo, Washington, DC. September, 2019.

Nabulsi NA, Martin MT, Sharp LK, Koren DE, Teply R, Zuckerman A, Lee TA. Prediction model of treatment failure among chronic HCV. Poster presented to the International Society for Pharmacoeconomics and Outcomes (ISPOR) Annual Meeting, New Orleans, LA. May, 2019.

Crothers G, Shah N, Kim M, Zuckerman A. Development of a quality measures tool for the utilization of tyrosine kinase inhibitors in non-small cell lung cancer: an integrated specialty pharmacy initiative. Poster presented to the Pharmacy Quality Alliance Annual Meeting, Baltimore, MD. May, 2019.

Ward-Isbell A, Peter M. Converting prescriptions to 90-day supply increases specialty pharmacy technician efficiency. Poster presented to the Pharmacy Quality Alliance Annual Meeting, Baltimore, MD. May, 2019.

Haydek J, Shah N, Zuckerman A, Wong R, Garrett A, Duley C, Annis K, Wagnon J, Dalal R, Scovile E, Beaulieu D, Schwartz D, Slaughter J, Horst S. Non-adherence to self-injectable biologic medication in patients with moderate to severe inflammatory bowel disease is associated with increased healthcare resource utilization. Poster presented to the Digestive Disease Week Annual Meeting, San Diego, CA. May, 2019.

Johnson K, Haffler Z, Miller L. Pharmacist managed lithium in an inpatient academic medical center. Poster presented to the College of Psychiatric and Neurologic Pharmacists Annual Meeting, Salt Lake City, UT. April, 2019.

Livezey S, McCormick R, Shah N, Choi L, DeClercq J, Zuckerman A. Impact of specialty pharmacist integration on time to medication access for pimavanserin. Poster presented to the College of Psychiatric and Neurologic Pharmacists Annual Meeting, Salt Lake City, UT. April, 2019.

Cherry E, Jolly J, Zuckerman A, Peter M. Adherence to specialty medications: assessing rates and correlates of nonadherence at an integrated specialty pharmacy. Poster presented to the Academy of Managed Care and Specialty Pharmacy Annual Meeting, San Diego, CA. March, 2019.

Nix R, Looney B, Lamb C, Peter M, Zuckerman A. A targeted approach to reducing rates of discontinuation and dose reduction in patients receiving sorafenib or regoranfenib. Poster presented to the Academy of Managed Care and Specialty Pharmacy Annual Meeting, San Diego, CA. March, 2019. *Awarded Gold Ribbon Abstract Award

Chelewski R, Johnson K, Zuckerman A, Peter M, DeClercq J, Choi L, Langone A. Development of a pharmacy collaborative practice agreement to improve efficiency and management of prescribing in a renal transplant clinic. Poster presented to the Academy of Managed Care and Specialty Pharmacy Annual Meeting, San Diego, CA. March, 2019. *Awarded Gold Ribbon Abstract Award

Peter M, Chakrabarti A, Gipson H, Gregory WT, DeClercq J, Choi L, Gibbs K, Tanner SB. Lapses and discontinuations in denosumab therapy: associations with fracture incidence. Poster presented to the International Society for Clinical Densitometry Annual Meeting, Kuala Lumpur, Malaysia. March, 2019.

Berger N, Peter M, DeClercq J, Choi L, Zuckerman A. Adherence to disease-modifying anti-rheumatic drugs in patients in an integrated clinic and specialty pharmacy. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Anaheim, CA. December, 2018.

Zuckerman A, Peter M, Johnson J, Miller K, Chastain C. Referral source matters: the hepatitis c cascade of care for traditional versus emergency department referrals. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Anaheim, CA. December, 2018.

Cornell RF, Goldhaber S, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Harrell S, Hall R, Wyatt H, Piazza G. Prospective study of apixaban for primary prevention of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory therapy, a 3-month interim analysis. Poster presented to the Annual Meeting & Exposition of the American Society of Hematology, San Diego, CA. December, 2018.

Koren D, Zuckerman A, Teply R, Nabulsi N, Lee T, Martin MT. Expanding hepatitis c virus care and cure: national experience using a clinical pharmacist-driven model. Poster presented to the American Association of the Study of Liver Diseases (AASLD) The Liver Meeting, San Francisco, CA. November, 2018.

Wyatt H, Zuckerman A, Peter M, Starks S, Maulis M, Declercq J, Choi L, Jagasia M. Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks. Poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, Orlando, FL. October, 2018.

Paolella D, Zuckerman A, Cherry E, Jolly J. Closing the gap: identifying rates and reasons for nonadherence in a specialty population. Poster presented to the Academy of Managed Care Pharmacy Nexus Annual Meeting, Orlando, FL. October, 2018. *Awarded Silver Ribbon Abstract Award

Reynolds V, Peter M, Jolly J, Chinn M, Nwosu S, Choi L, Zuckerman A. Impact of an integrated clinical and specialty pharmacy service model on access to PCSK9 inhibitor therapy. Encore poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2018.

Cherry E, Jolly JA, Zuckerman A. Using rates of non-adherence to identify opportunities for intervention in outpatient specialty clinics. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2018.

Lines TH, Carver AB, Zuckerman A, Chastain CA. Persistent viremia on DAA therapy: real-world experience, interventions, and outcomes. Poster presented to the American College of Clinical Pharmacy Updates in Therapeutics, Jacksonville, FL. February, 2018.

Douglas A, Chastain C, Zuckerman A. Adjustments to antiretroviral therapy regimens in co-infected human immunodeficiency virus and hepatitis c virus patients. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Orlando, FL. December, 2017.

Singleton E, Boils B, Litten K, Burkes S, Zuckerman A. Factors that impact treatment completion of teriparatide. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Orlando, FL. December, 2017.

Chinn M, Reynolds V, Jolly J, Zuckerman A, Kelley T. Impact of an integrated clinical and specialty pharmacy service model on access to PCSK9 inhibitor therapy. Poster presented to the American Society of Health Systems Pharmacists Midyear Clinical Meeting and Exhibition, Orlando, FL. December, 2017.

Zuckerman A, Douglas A, Farris K, Chastain C. Merit project: optimizing the hepatitis c cascade of care in the direct-acting antiviral era. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ. October, 2017.

Bagwell A, Douglas A, Farris K, Chastain C. Evaluation of the hepatitis c cascade of care in a multidisciplinary infectious diseases clinic. Poster presented to ID Week, San Diego, CA. October, 2017.

Bagwell A, Chastain C. Improvements following clinical pharmacist integration in the management of hepatitis c. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Jolly J, Markley B, Holder G, Banks A, Zuckerman S, Zuckerman A. Improving adherence to multiple sclerosis disease modifying therapies through an integrated specialty pharmacy model. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Mitchell R, Shah N, Terry S, Slack S, Zuckerman A, Jolly J. Improving medication adherence in pulmonary arterial hypertension: an integrated specialty pharmacy approach. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Carver A, Porayko M. Retreatment of genotype 1 hepatitis c virus with sofosbuvir, simeprevir, and ribavirin following treatment failure with an ns5a-containing direct-acting antiviral regimen. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Singleton E, Boils B, Litten K, Burkes S, Zuckerman A. Assessing the impact of high touch specialty pharmacy services in patients receiving teriparatide. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017.

Bagwell A, Farris K, Chastain C. MeRit project: optimizing the hepatitis c cascade of care in the direct-acting antiviral era. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October, 2016.

Bagwell A, Chastain C. An interdisciplinary team approach to hepatitis c evaluation and treatment: assessing the impact of clinical pharmacist involvement on HCV clinical practice and treatment. Poster presented to the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October, 2016.

Nelsen C, Carver A. Real world assessment of all-oral, sofosbuvir-based, hepatitis c therapy at an academic medical center with integrated specialty pharmacy services. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2016.

Beavers J, Nelsen C, Carver A, Bagwell A. Real world assessment of interferon free oral sofosbuvir based therapy in hepatitis c patients. Poster presented to the Southeastern Resident Conference (SERC), Athens, GA. May, 2016.